Related Experiment Video
Updated: Sep 14, 2025

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
TSC22D1 is a newly identified inhibitor of insulin secretion in pancreatic beta cells
Sümbül Yıldırım1,2,3,4, Amit Mhamane3,4, Svenja Lösch1,3,4
1Department of Endocrinology and Metabolism, Joint Heidelberg IDC Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.
Abstract:
The loss of pancreatic beta cell function leads to chronically high blood glucose levels, contributing to diabetes mellitus, one of the leading causes of morbidity and mortality worldwide. Understanding the molecular mechanisms that regulate beta cell function could pave the way for the development of more effective antidiabetic treatments. In this study, we identify the evolutionarily conserved transforming growth factor β-1 stimulated clone D1 (TSC22D1) protein as a previously unknown regulator of beta cell function. TSC22D1 depletion in INS-1E cells enhances the expression of key beta cell identity genes, including Ins1, Ins2, Pdx1, Slc2a2, and Nkx6.1, and promotes glucose-stimulated insulin secretion without altering intracellular insulin content. Mechanistically, TSC22D1 and Forkhead box protein O1 (FoxO1) interact and regulate each other in a reciprocal manner to control beta cell function. Our follow-up interactome and RNA-Seq analyses reveal that TSC22D1 is crucial for glucose-responsive cellular processes in beta cells, including mRNA processing, ribonucleoprotein complex biogenesis, and Golgi vesicle transport. Overall, our findings indicate that TSC22D1 plays a significant role in regulating beta cell function at multiple levels, with potential implications for metabolic diseases, such as diabetes.
Insights
Researchers discovered that the TSC22D1 protein regulates pancreatic beta cell function and insulin secretion. This finding offers new insights into potential treatments for diabetes mellitus.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Pancreatic beta cell dysfunction causes high blood glucose levels, leading to diabetes mellitus, a major global health issue.
- Identifying molecular regulators of beta cell function is crucial for developing novel antidiabetic therapies.
Purpose of the Study:
- To identify novel regulators of pancreatic beta cell function.
- To investigate the role of the transforming growth factor β-1 stimulated clone D1 (TSC22D1) protein in beta cell function and glucose homeostasis.
Main Methods:
- Utilized INS-1E rat insulinoma cell line for experiments.
- Performed gene expression analysis (RNA-Seq) and protein-protein interaction studies (interactome analysis).
- Assessed glucose-stimulated insulin secretion and intracellular insulin content.
Main Results:
- Depletion of TSC22D1 enhanced key beta cell identity genes (Ins1, Ins2, Pdx1, Slc2a2, Nkx6.1) and promoted glucose-stimulated insulin secretion.
- Demonstrated a reciprocal interaction and regulation between TSC22D1 and Forkhead box protein O1 (FoxO1).
- Identified TSC22D1's critical role in glucose-responsive processes like mRNA processing, ribonucleoprotein complex biogenesis, and Golgi vesicle transport.
Conclusions:
- TSC22D1 is a novel, evolutionarily conserved regulator of pancreatic beta cell function.
- TSC22D1 influences beta cell function at multiple molecular and cellular levels.
- Targeting TSC22D1 may offer therapeutic potential for metabolic diseases, including diabetes mellitus.
Related Concept Videos
Insulin Secretory Vesicles
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Dipeptidyl Peptidase 4 Inhibitors
Insulin: The Receptor and Signaling Pathways
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Cell Specific Gene Expression

